Combined metabolomics and microbiota analysis reveals the therapeutic effect of indole-3-propionic acid on ovariectomy-induced osteoporosis
- 1Central Hospital Affiliated to Shenyang Medical College
- 2General Hospital of Northern Theater Command
Abstract
Osteoporosis is a process of bone tissue destruction jointly caused by chronic inflammation and oxidative stress. Indole-3-propionic acid (IPA), as a metabolic molecule of the gut microbiota, exerts anti-inflammatory and antioxidant properties. However, the role of IPA in ovariectomy-induced osteoporosis in rats remains unclear. We utilized ELISA and qRT-PCR to measure cytokine levels in serum and the mRNA expression of bone metabolism-related genes, respectively. Meanwhile, bone microstructure was analyzed using CT scanning technology. Additionally, we conducted non-targeted metabolomics and 16 S rDNA gene sequencing studies on mouse fecal samples, employing multivariate statistical analysis for data visualization. IPA administration significantly attenuated the elevation of inflammatory mediators (TNF-α, IL-1β, IL-6) in OVX rats, while enhancing anti-inflammatory IL-10 levels. It could alter biochemical markers (Ca, P, ALP, CTX-1 and PINP) and suppress the expression of critical osteoclast differentiation genes (NFATc1, CTSK, ACP5, OSCAR), preventing OVX-induced bone loss. Additionally, the bone microstructure improved. Metabolomic profiling revealed IPA’s regulatory role in fatty acid and amino acid metabolic pathways. Phloretin may serve as biomarker for the bone-protective effects of IPA. Additionally, IPA restored the balance of the Bacteroidota/Firmicutes gut microbiota. These findings underscore IPA’s therapeutic potential, providing a scientific rationale for developing IPA-based interventions for osteoporosis management.
Related
- Gut microbiota-immune-bone axis in osteoporosis: mechanisms and intervention strategies
- Therapeutic potential of hydroxybenzoic acid and lentinan in mitigating glucocorticoid-induced osteoporosis: an experimental study
- Synovial SLC1A5-Associated Amino Acid Metabolic Features in Knee Osteoarthritis: An Integrated Analysis of Synovial Transcriptomics, Fecal Metabolomics, and Gut Microbiota
- Gut microbiota and serum metabolomics in children with human parainfluenza virus infection.
- Gut microbiota modulation of gastrointestinal cancers: from dysbiosis signatures to therapeutic interventions
BibTeX
@article{liang2026combined,
title = {{Combined metabolomics and microbiota analysis reveals the therapeutic effect of indole-3-propionic acid on ovariectomy-induced osteoporosis}},
author = {Liang A. and Na Gong and Sheng Li and Wenzheng Lv and Yingnan Ji},
journal = {Scientific Reports},
year = {2026},
month = aug,
doi = {10.1038/s41598-026-61654-9},
url = {https://doi.org/10.1038/s41598-026-61654-9},
note = {CC BY},
}
RIS
TY - JOUR
TI - Combined metabolomics and microbiota analysis reveals the therapeutic effect of indole-3-propionic acid on ovariectomy-induced osteoporosis
AU - Liang A.
AU - Na Gong
AU - Sheng Li
AU - Wenzheng Lv
AU - Yingnan Ji
PY - 2026
DA - 2026/08/01
JO - Scientific Reports
DO - 10.1038/s41598-026-61654-9
UR - https://doi.org/10.1038/s41598-026-61654-9
AB - Osteoporosis is a process of bone tissue destruction jointly caused by chronic inflammation and oxidative stress. Indole-3-propionic acid (IPA), as a metabolic molecule of the gut microbiota, exerts anti-inflammatory and antioxidant properties. However, the role of IPA in ovariectomy-induced osteoporosis in rats remains unclear. We utilized ELISA and qRT-PCR to measure cytokine levels in serum and the mRNA expression of bone metabolism-related genes, respectively. Meanwhile, bone microstructure was analyzed using CT scanning technology. Additionally, we conducted non-targeted metabolomics and 16 S rDNA gene sequencing studies on mouse fecal samples, employing multivariate statistical analysis for data visualization. IPA administration significantly attenuated the elevation of inflammatory mediators (TNF-α, IL-1β, IL-6) in OVX rats, while enhancing anti-inflammatory IL-10 levels. It could alter biochemical markers (Ca, P, ALP, CTX-1 and PINP) and suppress the expression of critical osteoclast differentiation genes (NFATc1, CTSK, ACP5, OSCAR), preventing OVX-induced bone loss. Additionally, the bone microstructure improved. Metabolomic profiling revealed IPA’s regulatory role in fatty acid and amino acid metabolic pathways. Phloretin may serve as biomarker for the bone-protective effects of IPA. Additionally, IPA restored the balance of the Bacteroidota/Firmicutes gut microbiota. These findings underscore IPA’s therapeutic potential, providing a scientific rationale for developing IPA-based interventions for osteoporosis management.
SN - 2045-2322
ER -